KK Women's and Children's Hospital will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Clin Assoc Prof Lim Geok Hoon

FRCSEd (Gen), MMed (Spore), MRCS (UK), MBBS (Spore)

Head & Senior Consultant

KK Women's and Children's Hospital KK Women's and Children's Hospital

Specialty: Breast Surgery, General Surgery

Clinical Appointments

Head & Senior Consultant

KK Breast Centre

Academic Appointments

Clinical Associate Professor

Oncology Academic Clinical Programme

About

A/Prof Lim Geok Hoon is trained in oncoplastic breast surgery and believes that achieving a good cosmetic breast result is as paramount as ensuring a safe oncological outcome. She has several publications, with most of her work focusing specifically on surgical oncoplastic techniques most applicable to Asian women. She also has a special interest in genetic breast cancer, which is why she pursued a year-long fellowship in the United Kingdom on breast cancer genetics and oncoplastic surgery. She founded the Singapore Breast Oncoplastic Surgery Symposium (SBOSS) in 2015 and developed the world's first virtual simulator for teaching oncoplastic surgery. She also pioneered the minimal scar mastectomy technique.

Education and Training

  • FRCSEd (Gen) 2010
  • MMed, Singapore, 2006
  • MRCS, Edinburgh UK, 2006
  • MBBS, National University of Singapore, 2002

Professional Appointments and Committee Memberships

  • Clinical Associate Professor, Oncology Academic Clinical Program, Duke- NUS Medical School
  • Clinical Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore
  • Organising Chairman, Singapore Breast Oncoplastic Surgery Symposium (SBOSS), 2015 – present
  • Head of KKH breast department 1st oct 2020- present
  • Editorial Board Member of Translational Breast Cancer Research from April 2025- present

Awards

  • GCEO Outstanding Clinician Award 2025
  • KKH Service from the heart 2024
  • 20 years Long service award (KKH, SingHealth) 2024
  • SingHealth Publish! Award 2023
  • Covid-19 Resilience Medal 2023
  • Singapore Health Quality Service Awards 2023 (Star)
  • Merit Team Award for the KKH Target Zero Harm Awards 2022
  • Merit poster award at SGCRS/WIRES 2022
  • HQSS 1st runner up oral presentation 2022
  • SingHealth Value Driven Care poster award 2022
  • Good poster award at GBCC (S. Korea) 2022
  • Singapore Health Quality Service Award 2022 (Gold)
  • Best poster for Asia Pacific breast cancer summit 2021
  • Singapore Health Quality Service Award 2020 (Gold)
  • Best Diagnostic Scientific Poster award at SGCR & WIRES 2019
  • Scientific poster (Merit) award at Radiology Asia 2018
  • Best Educational poster award at Radiology Asia 2017
  • Singapore Health Quality Service Award 2017 (Star)
  • Singapore Health Quality Service Award 2016 (Gold)
  • Service from the heart award 2014
  • Singapore Medical Journal Best Research Paper Awards 2014 – 3rd Prize
  • Singapore Health Quality Service Award 2014 (Silver)
  • Long service award 2013
  • HMDP award for breast cancer genetics and oncoplastic surgery 2012
  • Best oral presentation for NUH Pitch for Fund 2009.
  • Merit award for basic medical sciences (Chemistry of cell and genetics) 1997.

Research Interests

  • Oncoplastic breast surgery
  • Breast cancer genetics

Research Trials

  • Uncovering the molecular landscape of breast cancer and drug-resistant breast cancer in local Singapore community (2024 – present)
  • KKH Academic Medicine (AM) Research Grant - Feasibility of tailoring axillary surgery based on the molecular subtype and nodal burden of breast cancer patients (2023 – present)
  • Assessing the outcomes of selective axillary dissection in breast cancer patients post neoadjuvant chemotherapy: A prospective study (2020 - present)
  • Pilot study on the feasibility of cryotherapy as an alternative treatment for phyllodes tumours/breast fibroepithelial lesions (FELs) needing surgery (2019 – present)
  • Development of Novel 3D Customised Implants for Partial Mastectomy Following Cancer Surgery: A Feasibility Study. 1st April 2018- 1st Oct 2018.
  • AMEI education grant 2017- Evaluating the feasibility of a novel breast oncoplastic surgery simulation (BOSS) mark-up model as a training tool to teach pre-operative incision marking- 1st July 2018-30th June 2020.
  • KKH Health Fund Research Grant-Feasibility of a novel method of axilla staging by using ultrasound visible clips (UVCs) to mark the involved axillary lymph nodes before neoadjuvant chemotherapy (NACT) in breast cancer patients- Oct 2017- 30th Sept 2019.
  • Development of a novel Breast Oncoplastic Surgery Stimulation (BOSS) Markup 3D model as a surgical training tool- 1st Aug 2017- 30th Nov 2017.
  • NUH Pitch for Fund (Evaluation of Syndecan-1 and 2 as Potential Biomarkers and Prognostic Factors for Breast Carcinoma in Asian Women) in 2009-2010.

Publications

  • Targeted axillary dissection in breast cancer patients with metastatic nodal disease: a prospective study on localization techniques and oncological outcomes. Lim GH, Al Shukairi AM, Lee YS, Teo SY, Yan Z, Tan QT, Gudi M, Ng RP, Wong FY. Gland Surg. 2025 Aug 31;14(8):1529-1538. doi: 10.21037/gs-2025-166. Epub 2025 Aug 20. PMID: 40948928; PMCID: PMC12432960.
  • Fibromatosis-Like Metaplastic Carcinoma of the Breast: A Challenging Diagnosis With Potential Pitfalls. Laokulrath N, Gudi MA, Tan PH, Tan TYZ, Lim GH. Int J Surg Pathol. 2025 Aug;33(5):1224-1229. doi: 10.1177/10668969241300498. Epub 2024 Dec 18. PMID: 39692324.
  • Integrating multimodal ultrasound imaging for improved radiomics sentinel lymph node assessment in breast cancer. Yang ZQ, Zhang Y, Lu F, Yang T, Shan J, Jiang Q, Lim GH, Bertucci F, Du H, Zhu YC. Gland Surg. 2025 Jul 31;14(7):1348-1365. doi: 10.21037/gs-2025-223. Epub 2025 Jul 25. PMID: 40771387; PMCID: PMC12322757.
  • Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. Zanti M, O'Mahony DG, Parsons MT, Dorling L, Dennis J, Boddicker NJ, Chen W, Hu C, Naven M, Yiangou K, Ahearn TU, Ambrosone CB, Andrulis IL, Antoniou AC, Auer PL, Baynes C, Bodelon C, Bogdanova NV, Bojesen SE, Bolla MK, Brantley KD, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chang-Claude J, Chen F, Chenevix-Trench G; NBCS Collaborators; Conroy DM, Czene K, De Nicolo A, Domchek SM, Dörk T, Dunning AM, Eliassen AH, Evans DG, Fasching PA, Figueroa JD, Flyger H, Gago-Dominguez M, García-Closas M, Glendon G, González-Neira A, Grassmann F, Hadjisavvas A, Haiman CA, Hamann U, Hart SN, Hartman MBA, Ho WK, Hodge JM, Hoppe R, Howell SJ; kConFab Investigators; Jakubowska A, Khusnutdinova EK, Ko YD, Kraft P, Kristensen VN, Lacey JV, Li J, Lim GH, Lindström S, Lophatananon A, Luccarini C, Mannermaa A, Martinez ME, Mavroudis D, Milne RL, Muir K, Nathanson KL, Nuñez-Torres R, Obi N, Olson JE, Palmer JR, Panayiotidis MI, Patel AV, Pharoah PDP, Polley EC, Rashid MU, Ruddy KJ, Saloustros E, Sawyer EJ, Schmidt MK, Southey MC, Tan VK, Teo SH, Teras LR, Torres D, Trentham-Dietz A, Truong T, Vachon CM, Wang Q, Weitzel JN, Yadav S, Yao S, Zirpoli GR, Cline MS, Devilee P, Tavtigian SV, Goldgar DE, Couch FJ, Easton DF, Spurdle AB, Michailidou K. Nat Commun. 2025 May 25;16(1):4852. doi: 10.1038/s41467-025-59979-6. PMID: 40413188; PMCID: PMC12103537.
  • Risking arm lymphedema in more than a hundred patients to benefit one patient-is it worth it? Lim GH, Yap YS, Lim RJ, Leong LCH. Gland Surg. 2025 Apr 30;14(4):781-784. doi: 10.21037/gs-2025-34. Epub 2025 Apr 25. PMID: 40405964; PMCID: PMC12093178.
  • Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial. Jiao D, Qiao J, Sun X, Wang C, Lu Z, Zhang C, Li L, Yan M, Feng Y, Zhou Y, Deng M, Liu X, Ma M, Jia H, Xia Q, Lim GH, Ishii N, Orlandi A, Hernanz F, Chen X, Liu Z. Clin Cancer Res. 2025 Apr 21. doi: 10.1158/1078-0432.CCR-25-0289. Epub ahead of print. PMID: 40260648.
  • Natural History and Outcome of Cryoablation for Breast B3 Fibroepithelial Lesion: A Prospectively Reported Case and Literature Review. Ang BWG, Gudi M, Cham MT, Ng RP, Teo SY, Lee YS, Leong LCH, Lim GH. J Clin Ultrasound. 2025 Apr 28. doi: 10.1002/jcu.24044. Epub ahead of print. PMID: 40290090.
  • Initial Outcomes of a Novel Technique of Nipple Sparing Mastectomy Without Reconstruction. Lim GH, Liew N, Allen JC. Cancers (Basel). 2025 Mar 14;17(6):984. doi: 10.3390/cancers17060984. PMID: 40149318; PMCID: PMC11940564.
  • Impact of Shenling Baizhu Powder on lipid profiles and body mass index in breast cancer patients under adjuvant chemotherapy: a retrospective study. Song J, Jin Y, Yu Q, Wu H, Li H, Lim GH, Antonini M, Gao X. Transl Cancer Res. 2025 Mar 30;14(3):1952-1970. doi: 10.21037/tcr-2024-2658. Epub 2025 Mar 18. PMID: 40224979; PMCID: PMC11985205.
  • Factors affecting mammogram breast cancer surveillance effectiveness in the ipsilateral and contralateral breast. Hamzah JL, Phua JKS, Chan WT, Teo SY, Tan VK, Lim GH, Tan BKT, Lim SH, Tan PH, Allen JC, Leong LCH. Clin Imaging. 2024 Dec;116:110308. doi: 10.1016/j.clinimag.2024.110308. Epub 2024 Oct 5. PMID: 39423691.
  • Fibromatosis-Like Metaplastic Carcinoma of the Breast: A Challenging Diagnosis With Potential Pitfalls. Laokulrath N, Gudi MA, Tan PH, Tan TYZ, Lim GH. Int J Surg Pathol. 2024 Dec 18:10668969241300498. doi: 10.1177/10668969241300498. Epub ahead of print. PMID: 39692324.
  • Using Machine Learning Models to Predict Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Rahadian RE, Tan HQ, Ho BS, Kumaran A, Villanueva A, Sng J, Tan RSYC, Tan TJY, Tan VKM, Tan BKT, Lim GH, Cai Y, Nei WL, Wong FY. JCO Clin Cancer Inform. 2024 Nov;8:e2400071. doi: 10.1200/CCI.24.00071. Epub 2024 Nov 22. PMID: 39576956.
  • Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study. Kim J, Kim J, Seo KH, Lee KH, Park YH, Lin CH, Lu YS, Ueno T, Yap YS, Wong FY, Tan VKM, Lim GH, Tan SM, Yeo W, Liu Q, Leung R, Naito Y, Li H, Lee HB, Han W, Im SA; Asian Breast Cancer Cooperative Group. ESMO Open. 2024 Nov;9(11):103732. doi: 10.1016/j.esmoop.2024.103732. Epub 2024 Oct 15. PMID: 39413678; PMCID: PMC11530587.
  • Long-Term Oncologic Outcomes of Omitting Axillary Surgery in Breast Cancer Patients with Chest Wall Recurrence after Mastectomy. Lim GH, Alcantara VS, Allen JC Jr, Saffari SE, Tan VKM, Tan KTB, Ngaserin S, Tan SM, Leong LCH, Wong FY. Cancers (Basel). 2024 Jul 29;16(15):2699. doi: 10.3390/cancers16152699. PMID: 39123428; PMCID: PMC11312264.
  • Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ. Pang J, Yan Z, Tan QT, Allen JC, Wang M, Lim GH. Clin Breast Cancer. 2024 Jun;24(4):363-367. doi: 10.1016/j.clbc.2024.02.002. Epub 2024 Feb 5. PMID: 38458843.
  • Characterizing the Relationship between Expression Quantitative Trait Loci (eQTLs), DNA Methylation Quantitative Trait Loci (mQTLs), and Breast Cancer Risk Variants. Ho PJ, Khng A, Tan BK, Khor CC, Tan EY, Lim GH, Yuan JM, Tan SM, Chang X, Tan VKM, Sim X, Dorajoo R, Koh WP, Hartman M, Li J. Cancers (Basel). 2024 May 30;16(11):2072. doi: 10.3390/cancers16112072. PMID: 38893190; PMCID: PMC11171367.
  • A comprehensive analysis of imaging features and clinical characteristics to differentiate malignant from non-malignant mammographic architectural distortion. Zhang S, Shao Z, Yi H, Liu P, Liu F, Lu H, Lim GH, Xu W. Gland Surg. 2024 May 30;13(5):669-683. doi: 10.21037/gs-24-110. Epub 2024 May 27. PMID: 38845839; PMCID: PMC11150194.
  • 1Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study. Tan RYC, Ong WS, Lee KH, Park S, Iqbal J, Park YH, Lee JE, Yu JH, Lin CH, Lu YS, Ono M, Ueno T, Naito Y, Onishi T, Lim GH, Tan SM, Lee HB, Koh J, Han W, Im SA, Tan VKM, Phyu N, Wong FY, Tan PH, Yap YS. J Natl Compr Canc Netw. 2024 May 14;22(2 D):e237121. doi: 10.6004/jnccn.2023.7121. PMID: 38744306.
  • Determining the Need for Metastatic Staging in Patients with Bilateral Breast Cancers. Alcantara VS, Chan SMZ, Wong FY, Allen JC, Lim GH. Curr Oncol. 2024 Apr 2;31(4):1936-1946. doi: 10.3390/curroncol31040145. PMID: 38668048; PMCID: PMC11048779.
  • A WeChat-based nursing intervention program improves the postoperative rehabilitation of breast cancer patients: results from a randomized controlled trial. Wang LP, Yao LH, Wang D, Lim GH, Almaghrabi MY, Shen H, Yuan X, Liang SS. Gland Surg. 2024 Mar 27;13(3):383-394. doi: 10.21037/gs-24-40. Epub 2024 Mar 18. PMID: 38601277; PMCID: PMC11002481.
  • Use of axillary ultrasound to guide breast cancer management in the genomic assay era. Lim GH, Allen JC, Lee YS, Teo SY, Lau LC, Win T, Leong LCH. Breast Dis. 2024;43(1):19-23. doi: 10.3233/BD-230032. PMID: 38489166; PMCID: PMC10977404.
  • Is Metastatic Staging Needed for All Patients with Synchronous Bilateral Breast Cancers? Lim GH, Hoo JX, Shin YC, Choo RZT, Wong FY, Allen JC. Cancers (Basel). 2023 Dec 19;16(1):17. doi: 10.3390/cancers16010017. PMID: 38201445; PMCID: PMC10777992.
  • Alterations to DNA methylation patterns induced by chemotherapy treatment are associated with negative impacts on the olfactory pathway. Ho PJ, Khng AJ, Tan BK, Lim GH, Tan SM, Tan VKM, Tan RSYC, Lim EH, Iau PT, Chew YJ, Lim YY, Hartman M, Tan EY, Li J.  Breast Cancer Res. 2023 Nov 6;25(1):136. doi: 10.1186/s13058-023-01730-4. PMID: 37932858; PMCID: PMC10626732.
  • Savi Scout® wireless localisation of breast and axillary lesions: lessons learned from Singapore's early experience. Lim HJ, Leong LCH, Tan YY, Ong EMW, Tan VKM, Lim SZ, Yen Woo EK, Lee YS, Sim Y, Madhukumar P, Tee Tan BK, Sim LS, Lin Moey TH, Win T, Lim GH. Singapore Med J. 2023 Nov 10. doi: 10.4103/singaporemedj.SMJ-2021-412. Epub ahead of print. PMID: 38037778.
  • The practice patterns and perceptions of surgeons in Singapore regarding breast-conserving surgery. Ngaserin S, Yeo CB, Leong FQ, Tan VKM, Lim GH, Tan SM, Tan BK. Ann Acad Med Singap. 2023 Nov 29;52(11):639-642. doi: 10.47102/annals-acadmedsg.2023111. PMID: 38920152.
  • Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. Wilcox N, Dumont M, González-Neira A, Carvalho S, Joly Beauparlant C, Crotti M, Luccarini C, Soucy P, Dubois S, Nuñez-Torres R, Pita G, Gardner EJ, Dennis J, Alonso MR, Álvarez N, Baynes C, Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK, Castelao JE, Chang-Claude J, Cornelissen S, Dörk T, Engel C, Gago-Dominguez M, Guénel P, Hadjisavvas A, Hahnen E, Hartman M, Herráez B; SGBCC Investigators; Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M, Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der Kolk LE, Wahlström C, Wang Q, Perry JRB, Benitez J, Schmidt MK, Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P, Easton DF, Simard J. Nat Genet. 2023 Sep;55(9):1435-1439. doi: 10.1038/s41588-023-01466-z. Epub 2023 Aug 17. Erratum in: Nat Genet. 2023 Nov;55(11):2009. doi: 10.1038/s41588-023-01549-x. PMID: 37592023; PMCID: PMC10484782.
  • Can the size of chest wall recurrence after mastectomy in breast cancer patients predict the presence of systemic metastasis? Lim GH, Wong RLE, Alcantara VS, Ng RP, Tan QT, Lim SH, Yan Z, Pang J.  Gland Surg. 2023 May 30;12(5):586-592. doi: 10.21037/gs-22-673. Epub 2023 Apr 14. PMID: 37284720; PMCID: PMC10240426.
  • An unusual site for breast clip migration: A case report. Ang BWG, Lee YS, Lim GH. Radiol Case Rep. 2023 May 12;18(7):2487-2490. doi: 10.1016/j.radcr.2023.04.007. PMID: 37214331; PMCID: PMC10196917.
  • A comparison of the outcomes of a novel technique of Mini-Incision and Self-Express (MISE) for breast abscess with the conventional techniques: a retrospective comparative cohort study. Chan XT, Allen JC, Gudi M, Lim GH.  Ann Med Surg (Lond). 2023 Apr 14;85(5):1546-1549. doi: 10.1097/MS9.0000000000000658. PMID: 37229045; PMCID: PMC10205390.
  • Axillary management of breast cancer patients with isolated chest wall recurrence after mastectomy. Lim GH, Alcantara VS, Ng RP, Htein MMW, Tan QT, Lim SH, Yan Z. Ann Transl Med. 2023 Mar 31;11(6):240. doi: 10.21037/atm-22-3702. Epub 2023 Feb 24. PMID: 37082687; PMCID: PMC10113085.
  • Oncologic outcomes in breast cancer patients with metastatic nodes and pathological nodal response following neoadjuvant chemotherapy without axillary dissection: a literature review. Lim GH, Leong LCH. Ann Transl Med. 2023 Mar 15;11(5):218. doi: 10.21037/atm-22-4961. Epub 2023 Mar 9. PMID: 37007543; PMCID: PMC10061475.
  • Clinical presentations and outcomes of young women aged <40 yrs with Ductal carcinoma in situ. Yan Z, Ngeow J, Allen J, Lim GH. Breast Dis. 2023;42(1):299-303. doi: 10.3233/BD-230018. PMID: 37807772.
  • Conventional standard-sized bra with prosthesis or patient's bra with customized hand-knitted external prosthesis after mastectomy: Mixed-methods evaluation of patients' preferences. Ng RP, Allen JC, Chia YY, Lim GH. Breast Dis. 2023;42(1):375-382. doi: 10.3233/BD-230040. PMID: 38073368.
  • Patterns of breast cancer second recurrences in patients after mastectomy. Lim GH, Alcantara VS, Ng RP, Ng R, Allen JC, Htein MMW, Lim SH, Yan Z, Tan QT. Breast Cancer Res Treat. 2022 Dec;196(3):583-589. doi: 10.1007/s10549-022-06772-4. Epub 2022 Oct 26. PMID: 36287308.
  • Comments on: "Resection of Cavity Shave Margins Ir Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial". Lim GH. Ann Surg. 2022 Dec 1;276(6):e1117. doi: 10.1097/SLA.0000000000005279. Epub 2021 Nov 9. PMID: 35129492.
  • A First Reported Adjustable Breast Volume Simulator for Teaching Oncoplastic Surgery Marking: Adjustable Breast Oncoplastic Surgery Simulator. Lim GH, Lau JH, Lee J, Yen CC. Surg Innov. 2022 Dec;29(6):814-816. doi: 10.1177/15533506221092492. Epub 2022 Apr 28. PMID: 35484686.
  • Relevance of the MHC region for breast cancer susceptibility in Asians. Ho PJ, Khng AJ, Tan BK, Tan EY, Tan SM, Tan VKM, Lim GH, Aronson KJ, Chan TL, Choi JY, Dennis J, Ho WK, Hou MF, Ito H, Iwasaki M, John EM, Kang D, Kim SW, Kurian AW, Kwong A, Lophatananon A, Matsuo K, Mohd-Taib NA, Muir K, Murphy RA, Park SK, Shen CY, Shu XO, Teo SH, Wang Q, Yamaji T, Zheng W, Bolla MK, Dunning AM, Easton DF, Pharoah PDP, Hartman M, Li J. Breast Cancer. 2022 Sep;29(5):869-879. doi: 10.1007/s12282-022-01366-w. Epub 2022 May 11. PMID: 35543923; PMCID: PMC9385763.
  • Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients. Lim ZL, Ho PJ, Khng AJ, Yeoh YS, Ong ATW, Tan BKT, Tan EY, Tan SM, Lim GH, Lee JA, Tan VK, Hu J, Li J, Hartman M. BMC Med. 2022 Aug 4;20(1):239. doi: 10.1186/s12916-022-02440-y. PMID: 35922814; PMCID: PMC9351273.
  • Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results. Ong SS, Ho PJ, Khng AJ, Lim EH, Wong FY, Tan BK, Lim SH, Tan EY, Tan SM, Tan VKM, Dent R, Tan TJY, Ngeow J, Madhukumar P, Hamzah JLB, Sim Y, Lim GH, Pang JS, Alcantara VS, Chan PMY, Chen JJC, Kuah S, Seah JCM, Buhari SA, Tang SW, Ng CWQ, Li J, Hartman M. Cancers (Basel). 2022 May 31;14(11):2714. doi: 10.3390/cancers14112714. PMID: 35681694; PMCID: PMC9179461.
  • Determining the benefit of neoadjuvant chemotherapy in reduction of axillary dissection rates in Z0011 trial cohort with high nodal burden. Yan Z, Wong A, Ng RP, Lee YS, Lim MEA, Leong LCH, Allen J, Lim GH.  Gland Surg. 2022 May;11(5):788-794. doi: 10.21037/gs-22-7. PMID: 35694092; PMCID: PMC9177288.
  • Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification. Ho PJ, Ho WK, Khng AJ, Yeoh YS, Tan BK, Tan EY, Lim GH, Tan SM, Tan VKM, Yip CH, Mohd-Taib NA, Wong FY, Lim EH, Ngeow J, Chay WY, Leong LCH, Yong WS, Seah CM, Tang SW, Ng CWQ, Yan Z, Lee JA, Rahmat K, Islam T, Hassan T, Tai MC, Khor CC, Yuan JM, Koh WP, Sim X, Dunning AM, Bolla MK, Antoniou AC, Teo SH, Li J, Hartman M. BMC Med. 2022 Apr 26;20(1):150. doi: 10.1186/s12916-022-02334-z. PMID: 35468796; PMCID: PMC9040206.
  • HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis. Tan RSYC, Ong WS, Lee KH, Lim AH, Park S, Park YH, Lin CH, Lu YS, Ono M, Ueno T, Naito Y, Onishi T, Lim GH, Tan SM, Lee HB, Ryu HS, Han W, Tan VKM, Wong FY, Im SA, Tan PH, Chan JY, Yap YS. BMC Med. 2022 Mar 17;20(1):105. doi: 10.1186/s12916-022-02284-6. PMID: 35296300; PMCID: PMC8928638.
  • Associations between Pre-Diagnostic Physical Activity with Breast Cancer Characteristics and Survival. Lim ZL, Lim GH, Ho PJ, Khng AJ, Yeoh YS, Ong ATW, Tan BKT, Tan EY, Tan SM, Tan VK, Li J, Hartman M. Cancers (Basel). 2022 Mar 30;14(7):1756. doi: 10.3390/cancers14071756. PMID: 35406528; PMCID: PMC8997033.
  • Factors influencing decisions on contralateral symmetrisation procedure among patients with breast cancer. Lim GH, Choo CH, Allen JC Jr, Ng RP. Singapore Med J. 2022 Jan;63(1):42-46. doi: 10.11622/smedj.2020076. Epub 2020 May 27. PMID: 32460447; PMCID: PMC9251219.
  • Effect of pregnancy and lactation on a benign phyllodes tumour. Ooi LY, Lim GH, Gudi MA. BMJ Case Rep. 2022 Jan 13;15(1):e247340. doi: 10.1136/bcr-2021-247340. PMID: 35027387; PMCID: PMC8762099.
  • Usefulness of supplementary ultrasound surveillance in the detection of a second breast cancer in patients with ductal carcinoma in situ. Almalki HS, Lim A, Allen JC, Teo SY, Lim GH. Clin Breast Cancer. 2021 Dec;21(6):521-525. doi: 10.1016/j.clbc.2021.08.006. Epub 2021 Aug 20. PMID: 34544658.
  • Germline breast cancer susceptibility genes, tumor characteristics, and survival. Ho PJ, Khng AJ, Loh HW, Ho WK, Yip CH, Mohd-Taib NA, Tan VKM, Tan BK, Tan SM, Tan EY, Lim SH, Jamaris S, Sim Y, Wong FY, Ngeow J, Lim EH, Tai MC, Wijaya EA, Lee SC, Chan CW, Buhari SA, Chan PMY, Chen JJC, Seah JCM, Lee WP, Mok CW, Lim GH, Woo E, Kim SW, Lee JW, Lee MH, Park SK, Dunning AM, Easton DF, Schmidt MK, Teo SH, Li J, Hartman M. Genome Med. 2021 Dec 2;13(1):185. doi: 10.1186/s13073-021-00978-9. PMID: 34857041; PMCID: PMC8638193.
  • Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy. Lim SZ, Kusumawidjaja G, Mohd Ishak HM, Tan BKT, Tan SY, Hamzah JL, Madhukumar P, Yong WS, Wong CY, Sim Y, Lim GH, Lim SH, Tan SM, Wong FY, Tan VKM. Breast Cancer Res Treat. 2021 Oct;189(3):837-843. doi: 10.1007/s10549-021-06341-1. Epub 2021 Aug 3. PMID: 34342766.
  • Association of the initial number of sonographically abnormal nodes with nodal pathological response and its implication. Yan Z, Wong A, Ng RP, Lee YS, Allen JC, Lim GH. Clin Imaging. 2021 Oct;78:19-21. doi: 10.1016/j.clinimag.2021.03.002. Epub 2021 Mar 10. PMID: 33714921.
  • A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist. Zhou H, Chen H, Cheng C, Wu X, Ma Y, Han J, Li D, Lim GH, Rozen WM, Ishii N, Roy PG, Wang Q. Ann Transl Med. 2021 Jul;9(14):1174. doi: 10.21037/atm-21-2884. PMID: 34430615; PMCID: PMC8350626.
  • Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers. Ho PJ, Yeoh YS, Miao H, Lim SH, Tan EY, Tan BKT, Tan VKM, Tan SM, Yong WS, Wong FY, Madhukumar P, Chan CW, Iau PTC, Lee SC, Putti T, Buhari SA, Lee JY, Lim GH, Woo E, Yan Z, Chan PMY, Chen JJC, Lu SQ, Dent R, Lee WP, Mok CW, Seah JCM, Sim X, van Dam RM, Chia KS, Li J, Hartman M. PLoS One. 2021 Apr 26;16(4):e0250102. doi: 10.1371/journal.pone.0250102. PMID: 33901219; PMCID: PMC8075208.
  • Evaluation of Virtual Breast Oncoplastic Surgery Simulator (VBOSS) as a training tool. Lim GH, Lee J, Eng TC, Ng RP, Thever Y, Yen CC. Breast J. 2021 Feb;27(2):194-197. doi: 10.1111/tbj.14136. Epub 2020 Dec 20. PMID: 33342019.
  • Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy? Lim GH, Gudi M, Teo SY, Ng RP, Yan Z, Lee YS, Allen JC Jr, Leong LCH. Oncologist. 2020 Nov;25(11):e1621-e1627. doi: 10.1634/theoncologist.2020-0494. Epub 2020 Jul 7. PMID: 32537791; PMCID: PMC7648324.
  • Determining the factors affecting the visibilities of various clips in axillary nodes on magnetic resonance imaging (MRI). Algowiez R, Lee YS, Leong LCH, Lim GH, Teo SY. Breast J. 2020 Nov;26(11):2299-2301. doi: 10.1111/tbj.13981. Epub 2020 Jul 28. PMID: 32725760.
  • Evaluating the feasibility of a novel Marking Breast Oncoplastic Surgery Simulator (MBOSS) as a training tool for marking: a randomised trial. Lim GH, Wang X, Allen JC Jr, Ng RP, Tan BK, McCulley S, Lee HP. Gland Surg. 2020 Oct;9(5):1227-1234. doi: 10.21037/gs-20-476. PMID: 33224797; PMCID: PMC7667095.
  • European polygenic risk score for prediction of breast cancer shows similar performance in Asian women. Ho WK, Tan MM, Mavaddat N, Tai MC, Mariapun S, Li J, Ho PJ, Dennis J, Tyrer JP, Bolla MK, Michailidou K, Wang Q, Kang D, Choi JY, Jamaris S, Shu XO, Yoon SY, Park SK, Kim SW, Shen CY, Yu JC, Tan EY, Chan PMY, Muir K, Lophatananon A, Wu AH, Stram DO, Matsuo K, Ito H, Chan CW, Ngeow J, Yong WS, Lim SH, Lim GH, Kwong A, Chan TL, Tan SM, Seah J, John EM, Kurian AW, Koh WP, Khor CC, Iwasaki M, Yamaji T, Tan KMV, Tan KTB, Spinelli JJ, Aronson KJ, Hasan SN, Rahmat K, Vijayananthan A, Sim X, Pharoah PDP, Zheng W, Dunning AM, Simard J, van Dam RM, Yip CH, Taib NAM, Hartman M, Easton DF, Teo SH, Antoniou AC.  Nat Commun. 2020 Jul 31;11(1):3833. doi: 10.1038/s41467-020-17680-w. PMID: 32737321; PMCID: PMC7395776.
  • Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial). Lim GH, Teo SY, Gudi M, Ng RP, Pang J, Tan YS, Lee YS, Allen JC Jr, Leong LCH. Cancer Med. 2020 Mar;9(6):1978-1985. doi: 10.1002/cam4.2848. Epub 2020 Jan 22. PMID: 31970894; PMCID: PMC7064023.
  • Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging. Upadhyaya VS, Lim GH, Chan EYK, Fook-Chong SMC, Leong LCH. Breast J. 2020 Feb;26(2):162-167. doi: 10.1111/tbj.13635. Epub 2019 Sep 27. PMID: 31562691.
  • 5Trainees participation in breast cancer surgery: an assistance or a hinderance? Lim GH.  Gland Surg. 2019 Dec;8(6):596-598. doi: 10.21037/gs.2019.12.02. PMID: 32042665; PMCID: PMC6989908.
  • Reply: Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy. Lim GH, Baildam AD. Plast Reconstr Surg. 2019 Jul;144(1):140e. doi: 10.1097/PRS.0000000000005729. PMID: 31246846.
  • Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy. Lim GH, Teo SY, Allen JC Jr, Chinthala JP, Leong LCH. J Breast Cancer. 2019 Mar;22(1):67-76. doi: 10.4048/jbc.2019.22.e8. PMID: 30941234; PMCID: PMC6438828.
  • Eccrine poroma of the nipple: the first reported case. Lim GH, Abd Rashid F, Wong A. BMJ Case Rep. 2019 Mar 1;12(3):e228665. doi: 10.1136/bcr-2018-228665. PMID: 30826784; PMCID: PMC6398752.
  • How to do minimal scar mastectomy: first-reported novel concept of nipple sparing mastectomy without reconstruction. Lim GH. ANZ J Surg. 2018 Dec;88(12):1345-1346. doi: 10.1111/ans.14941. Epub 2018 Nov 1. PMID: 30384398.
  • Virtual breast oncoplastic surgery simulator (VBOSS): A novel training tool in breast surgery. Lim GH, Lee J, Yen CC.  Eur J Surg Oncol. 2018 Nov;44(11):1750-1753. doi: 10.1016/j.ejso.2018.07.062. Epub 2018 Aug 13. PMID: 30150156.
  • Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience. Courtney E, Chin XW, Yuen J, Li ST, Chen Y, Allen JC Jr, Tan V, Lim GH, Ngeow J. Fam Cancer. 2018 Oct;17(4):621-626. doi: 10.1007/s10689-018-0071-9. PMID: 29368260.
  • Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy. Lim GH, Baildam AD. Plast Reconstr Surg. 2018 Sep;142(3):607-610. doi: 10.1097/PRS.0000000000004635. PMID: 29878997.
  • Diagnostic dilemma of micropapillary variant of mucinous breast cancer. Lim GH, Yan Z, Gudi M. BMJ Case Rep. 2018 Aug 1;2018:bcr2018225775. doi: 10.1136/bcr-2018-225775. PMID: 30068578; PMCID: PMC6078245.
  • Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result. Lim GH, Upadhyaya VS, Acosta HA, Lim JMA, Allen JC Jr, Leong LCH. Eur J Surg Oncol. 2018 Jul;44(7):945-950. doi: 10.1016/j.ejso.2018.04.003. Epub 2018 Apr 12. PMID: 29705286.
  • Natural history of luminal A breast invasive ductal carcinoma in an elderly. Lim GH, Tay SPX, Gudi M. BMJ Case Rep. 2018 Apr 17;2018:bcr2018224218. doi: 10.1136/bcr-2018-224218. PMID: 29666097; PMCID: PMC5905775.
  • Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting. Li ST, Sun S, Lie D, Met-Domestici M, Courtney E, Menon S, Lim GH, Ngeow J. Psychooncology. 2018 Mar;27(3):998-1004. doi: 10.1002/pon.4627. Epub 2018 Jan 24. PMID: 29314485.
  • Clinical presentation of nipple duct ectasia: A rare glimpse. Lim GH, Gudi M. Breast J. 2018 Mar;24(2):209-210. doi: 10.1111/tbj.12873. Epub 2017 Jul 20. PMID: 28727211.
  • Milk fistula following puerperal breast abscess. Lim GH, Ng RP. Clin Case Rep. 2018 Feb 13;6(4):773-774. doi: 10.1002/ccr3.1413. PMID: 29636963; PMCID: PMC5889231.
  • Discordant correlation of breast adenoid cystic carcinoma on imaging and pathology: A case report and literature review on surgical management. Yan Z, Leong MY, Lim GH. Int J Surg Case Rep. 2018;42:196-199. doi: 10.1016/j.ijscr.2017.12.005. Epub 2017 Dec 8. PMID: 29268125; PMCID: PMC5737954.
  • Invasive papillary breast cancer with Paget's disease: first reported association and literature review. Lim GH, Chinthala JP, Gudi MA. BMJ Case Rep. 2018 Jan 4;2018:bcr2017222817. doi: 10.1136/bcr-2017-222817. PMID: 29301809; PMCID: PMC5786974.
  • Development of a surgical algorithm by using pre-operative imaging to predict mammoplasty cosmetic outcomes for large non-malignant tumours. Lim GH, Ng RP, Leong LCH. Gland Surg. 2017 Dec;6(6):649-653. doi: 10.21037/gs.2017.08.07. PMID: 29302481; PMCID: PMC5750303.
  • Natural history of metaplastic squamous cell breast cancer: a case report and literature review on surgical management. Lim GH, Acosta HA, Gudi MA. Gland Surg. 2017 Dec;6(6):738-741. doi: 10.21037/gs.2017.05.10. PMID: 29302494; PMCID: PMC5750308.
  • Oncoplastic round block technique has comparable operative parameters as standard wide local excision: a matched case-control study. Lim GH, Allen JC, Ng RP.  Gland Surg. 2017 Aug;6(4):343-349. doi: 10.21037/gs.2017.03.06. PMID: 28861374; PMCID: PMC5566664.
  • Evaluating the performance of National Comprehensive Cancer Network (NCCN) breast and ovarian genetic/familial high risk assessment referral criteria for breast cancer women in an Asian surgical breast clinic. Lim GH, Borje E, Allen JC Jr. Gland Surg. 2017 Feb;6(1):35-42. doi: 10.21037/gs.2016.11.05. PMID: 28210550; PMCID: PMC5293642.
  • Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia. Alcantara VS, Lim GH, Lim SH, Sultana R, Lee JA.J Surg Oncol. 2017 Apr;115(5):523-537. doi: 10.1002/jso.24559. Epub 2017 Feb 7. PMID: 28168712.
  • Outcome after neoadjuvant chemotherapy in Asian breast cancer patients. Lim LY, Miao H, Lim JS, Lee SC, Bhoo-Pathy N, Yip CH, Taib NA, Chan P, Tan EY, Lim SH, Lim GH, Woo E, Tan YS, Lee JA, Wong M, Tan PH, Ong KW, Wong FY, Yap YS, Hartman M. Cancer Med. 2017 Jan;6(1):173-185. doi: 10.1002/cam4.985. Epub 2016 Dec 20. PMID: 28000426; PMCID: PMC5269707.
  • Surgical techniques to avoid lateral dog ear of the mastectomy scar: A systematic review. Lim GH, Tan HF. Int J Surg. 2016 Feb;26:73-8. doi: 10.1016/j.ijsu.2015.12.068. Epub 2016 Jan 15. PMID: 26776364.
  • Applicability of Oncoplastic Breast Conserving Surgery in Asian Breast Cancer Patients. Lim G, Pineda LA.  Asian Pac J Cancer Prev. 2016;17(7):3325-8. PMID: 27509971.
  • Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. Lim GH, Tan PH, Jara-Lazaro AR, Thike AA, Sim WC, Yap VB, Yip GW. Singapore Med J. 2014 Sep;55(9):468-72. doi: 10.11622/smedj.2014115. PMID: 25273930; PMCID: PMC4293941.
  • Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: case report and literature review. Liong YV, Hong GS, Teo JG, Lim GH. World J Surg Oncol. 2013 Aug 7;11(1):179. doi: 10.1186/1477-7819-11-179. PMID: 23924035; PMCID: PMC3765146.
  • Natural history of small, "indeterminate" hepatic lesions in patients with colorectal cancer. Lim GH, Koh DC, Cheong WK, Wong KS, Tsang CB. Dis Colon Rectum. 2009 Aug;52(8):1487-91. doi: 10.1007/DCR.0013e3181a74d5e. PMID: 19617765.
  • Cholesterol atheroembolism of the colon can mimic the endoscopic features of pseudomembranous colitis. Lim GH, Roslani AC, Pang B, Bih-Shiou CT. Surg Laparosc Endosc Percutan Tech. 2008 Dec;18(6):616-8. doi: 10.1097/SLE.0b013e318180c956. PMID: 19098673.
  • Diagnostic laparoscopy in the evaluation of right lower abdominal pain: a one-year audit. Lim GH, Shabbir A, So JB. Singapore Med J. 2008 Jun;49(6):451-3. PMID: 18581015.